Andrew de Guttadauro

This profile gathers the share dealings of Andrew de Guttadauro in Oncolytics Biotech Inc. Between 3 July 2017 and 3 July 2020, the trades on record add up to 3 filings.

Every open-market trade on record is a purchase: 1 purchase worth €5,513, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise.

The latest filing, published on 7 July 2020, reports an option exercise in Oncolytics Biotech Inc. The last purchase on record was published on 12 December 2018, which is 2,875 days ago. The median gap between a trade and its publication by SEDI is 4 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.